AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2016
Sep 13, 2016
30786_dirs_2016-09-13_75bb5a1b-17c3-43b5-bfd9-49a5fe34ddb1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2016-09-10
Reporting Person: Crowley Michael (EVP, GBL Commercial Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-09-10 | Bio-Rad A Common Stock | M | 389 | — | Acquired | 2257 | Direct |
| 2016-09-11 | Bio-Rad A Common Stock | M | 976 | — | Acquired | 3233 | Direct |
| 2016-09-12 | Bio-Rad A Common Stock | S | 523 | $155.0195 | Disposed | 2710 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-09-10 | Restricted Stock Units | $0 | M | 389 | Disposed | Bio-Rad A Common Stock (389) | Direct | |
| 2016-09-11 | Restricted Stock Units | $0 | M | 376 | Disposed | Bio-Rad A Common Stock (376) | Direct | |
| 2016-09-11 | Restricted Stock Units | $0 | M | 600 | Disposed | Bio-Rad A Common Stock (600) | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Sold by the issuer on behalf of the reporting person to satisfy certain tax obligations in connection with the vesting of restricted stock units, all in accordance with a restricted stock unit award agreement.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.0174 to $155.0214, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F5: The restricted stock units vest in five equal annual installments beginning September 10, 2015.
F6: The restricted stock units vest in five equal annual installments beginning September 11, 2014.
F7: The restricted stock units vest in five equal annual installments beginning September 11, 2016.